These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 23772757

  • 1. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
    Darmon M, Vincent F, Camous L, Canet E, Bonmati C, Braun T, Caillot D, Cornillon J, Dimicoli S, Etienne A, Galicier L, Garnier A, Girault S, Hunault-Berger M, Marolleau JP, Moreau P, Raffoux E, Recher C, Thiebaud A, Thieblemont C, Azoulay E, Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique (GRRR-OH).
    Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
    [Abstract] [Full Text] [Related]

  • 2. Tumour lysis syndrome.
    Calvo Villas JM.
    Med Clin (Barc); 2019 May 17; 152(10):397-404. PubMed ID: 30612747
    [Abstract] [Full Text] [Related]

  • 3. Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie.
    Darmon M, Vincent F, Canet E, Mokart D, Pène F, Kouatchet A, Mayaux J, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Schlemmer B, Chevret S, Lemiale V, Azoulay E.
    Nephrol Dial Transplant; 2015 Dec 17; 30(12):2006-13. PubMed ID: 26597921
    [Abstract] [Full Text] [Related]

  • 4. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.
    Cortes J, Moore JO, Maziarz RT, Wetzler M, Craig M, Matous J, Luger S, Dey BR, Schiller GJ, Pham D, Abboud CN, Krishnamurthy M, Brown A, Laadem A, Seiter K.
    J Clin Oncol; 2010 Sep 20; 28(27):4207-13. PubMed ID: 20713865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Tumor lysis syndrome in intensive therapy: diagnostic and therapeutic encare].
    Burghi G, Berrutti D, Manzanares W.
    Med Intensiva; 2011 Apr 20; 35(3):170-8. PubMed ID: 21112673
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Acute renal failure in patients with tumour lysis sindrome].
    Poskurica M, Petrović D, Poskurica M.
    Srp Arh Celok Lek; 2016 Apr 20; 144(3-4):232-9. PubMed ID: 27483573
    [Abstract] [Full Text] [Related]

  • 11. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
    Vines AN, Shanholtz CB, Thompson JL.
    Ann Pharmacother; 2010 Oct 20; 44(10):1529-37. PubMed ID: 20841516
    [Abstract] [Full Text] [Related]

  • 12. Rasburicase for the treatment of tumor lysis in hematological malignancies.
    Malaguarnera G, Giordano M, Malaguarnera M.
    Expert Rev Hematol; 2012 Feb 20; 5(1):27-38. PubMed ID: 22272702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rasburicase in the prevention and treatment of tumour lysis syndrome.
    Mayne N, Keady S, Thacker M.
    Intensive Crit Care Nurs; 2008 Feb 20; 24(1):59-62. PubMed ID: 17698360
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.
    Feng X, Dong K, Pham D, Pence S, Inciardi J, Bhutada NS.
    J Clin Pharm Ther; 2013 Aug 20; 38(4):301-8. PubMed ID: 23550846
    [Abstract] [Full Text] [Related]

  • 18. The clinical management of tumour lysis syndrome in haematological malignancies.
    Will A, Tholouli E.
    Br J Haematol; 2011 Jul 20; 154(1):3-13. PubMed ID: 21554259
    [Abstract] [Full Text] [Related]

  • 19. Tumor lysis syndrome.
    Jeha S.
    Semin Hematol; 2001 Oct 20; 38(4 Suppl 10):4-8. PubMed ID: 11694945
    [Abstract] [Full Text] [Related]

  • 20. SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey.
    Bertrand Y, Mechinaud F, Brethon B, Mialou V, Auvrignon A, Nelken B, Notz-Carrère A, Plantaz D, Patte C, Urbieta M, Baruchel A, Leverger G, SFCE.
    J Pediatr Hematol Oncol; 2008 Apr 20; 30(4):267-71. PubMed ID: 18391694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.